Pacific Biosciences is a leader in the latest generation of human DNA sequencing.


Updates from The Motley Fool

Latest updates on Pacific Biosciences of California from Fool.com.


Stock Performance

PACB vs. S&P 500 | 2 Year Performance
View Interactive PACB Charts
Sponsored by

Key Data Points

Primary metrics and data points about Pacific Biosciences of California.
Current Price: $7.95
Prev Close: $7.91
Open: $7.88
Bid: $7.90
Ask: $8.07
Day's Range: $7.84 - $8.08
52wk Range: $3.58 - $14.00
Volume: 829,479
Avg Vol 1,747,201
Market Cap: $612.48M
P/E (ttm): -20.82
EPS (ttm): -$0.38
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Pacific Biosciences of California.
CAPS Rating 2 out of 5
 
209 Outperform
31 Underperform
CAPS All Stars
 
43 Outperform
14 Underperform

How do you think Pacific Biosciences of California will perform against the market?



You pick for Pacific Biosciences of California is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael Hunkapiller, CEO

78% Approve

Based on 15 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Pacific Biosciences of California.

Pacific Biosciences is a leader in the latest generation of human DNA sequencing.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers